Fitch affirms Pfizer IDR at AAA

Fitch Ratings has affirmed Pfizer Inc.'s AAA issuer default rating (IDR) and senior unsecured debt ratings, and F1+ short-term debt.

Simultaneously, Fitch has initiated an AAA bank loan rating.

The outlook remains stable.

Pfizer's credit profile is supported by its exceptional liquidity, strong balance sheet and conservative financial strategy, Fitch noted.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.